4.6 Article

A Randomized, Double-Blind, Placebo-Controlled, Delayed Start Study to Assess Rasagiline as a Disease Modifying Therapy in Parkinson's Disease (The ADAGIO Study): Rationale, Design, and Baseline Characteristics

Related references

Note: Only part of the references are listed.
Review Clinical Neurology

The role of radiotracer imaging in Parkinson disease

B Ravina et al.

NEUROLOGY (2005)